
Legalflyer archive
2020
List of pages
2019
List of pages

Rate claim over airport land fails to take off after Australian Federal Court decision
Councils’ ability to expand the areas over which they can charge federally leased airports “rates” has taken a blow in the recent Federal Court decision of Clarence City Council v Commonwealth of Australia [2019] FCA 1568.

New solutions to support rapid growth of the Aviation industry: New York Aviation Summit
The recently unveiled, multi-billion dollar airport regeneration projects being undertaken by The Port Authority of New York and New Jersey, as well as future prospects for asset-backed securitisations and other funding options for lessors and airlines, featured on the agenda at Norton Rose Fulbright’s annual New York Aviation Summit, which took place on November 15, 2018.
2018
List of pages

Finding the right Brexit path for aviation – Taking control versus market access
The following is an edited version of a presentation delivered to UK Transport in Europe (UKTiE) at the House of Lords on 5 September which sought to highlight legal considerations to be confronted in Brexit negotiations.
Publications récentes

Publication
L’affaire Vefghi Holding : êtes-vous bien « rattachées »?
The Federal Court of Appeal (FCA) in Canada v Vefghi Holding Corp recently released a highly anticipated decision regarding the timing for determining when two corporations interposed by a trust, hereinafter referred to as the Paying Corporation and the Corporate Beneficiary, must be “connected” for purposes of applying Part IV tax.

Publication
Données associées à des marchandises contrôlées : survol du cadre réglementaire
Le Programme des marchandises contrôlées (PMC) est le programme national de sécurité industrielle du Canada qui réglemente l’examen, la possession et le transfert des marchandises contrôlées.

Publication
L’approbation simplifiée que propose Santé Canada écourterait le délai avant d’intenter des litiges liés aux brevets visant des biosimilaires
Santé Canada a proposé un changement important à la réglementation des médicaments biosimilaires qui pourrait accélérer les litiges liés aux brevets visant des médicaments biologiques au Canada.
Abonnez-vous et restez à l’affût des nouvelles juridiques, informations et événements les plus récents...